Virginia Wealth Management Group Inc. Sells 1,148 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Virginia Wealth Management Group Inc. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 62.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 691 shares of the healthcare conglomerate’s stock after selling 1,148 shares during the quarter. Virginia Wealth Management Group Inc.’s holdings in UnitedHealth Group were worth $362,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of UNH. Norges Bank bought a new position in UnitedHealth Group during the fourth quarter worth $6,375,744,000. GAMMA Investing LLC boosted its stake in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. acquired a new position in UnitedHealth Group during the fourth quarter worth $1,914,740,000. Amundi raised its holdings in UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after buying an additional 2,991,470 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 over the last three months. 0.28% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Wolfe Research lowered their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a report on Wednesday, May 14th. Mizuho lowered their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Wells Fargo & Company reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Friday. Finally, TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $426.52.

View Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Trading Up 0.2%

Shares of UnitedHealth Group stock opened at $303.89 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The firm has a market cap of $275.67 billion, a PE ratio of 19.61, a PEG ratio of 1.37 and a beta of 0.45. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a 50 day simple moving average of $399.88 and a two-hundred day simple moving average of $479.36.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the business posted $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.91%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group’s payout ratio is presently 37.02%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.